Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Localised Prostate Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT02526368
What this trial is testing

Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Ivan de Kouchkovsky, MD 80
Testing effectiveness (Phase 2)Ended earlyNCT00860158
What this trial is testing

Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Noah Hahn, M.D. 1
Testing effectiveness (Phase 2)UnknownNCT03432780
What this trial is testing

Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer Stage IIIProstate Cancer Stage IV
Spanish Oncology Genito-Urinary Group 134
Early research (Phase 1)Study completedNCT03177460
What this trial is testing

Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8+3 more
M.D. Anderson Cancer Center 33
Not applicableStudy completedNCT03162523
What this trial is testing

Experiences With HDR-brachytherapy in Norway

Who this might be right for
Prostate Cancer
Oslo University Hospital 325
Testing effectiveness (Phase 2)Study completedNCT00561262
What this trial is testing

High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 60
Testing effectiveness (Phase 2)Looking for participantsNCT03753243
What this trial is testing

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Mark Garzotto, MD 32
Testing effectiveness (Phase 2)Study completedNCT02160353
What this trial is testing

Neo-adjuvant Abiraterone Prostate Study

Who this might be right for
High Risk Localised Prostate Carcinoma
Cancer Trials Ireland 45
Large-scale testing (Phase 3)Active Not RecruitingNCT02531516
What this trial is testing

An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS

Who this might be right for
Prostatic Neoplasms
Aragon Pharmaceuticals, Inc. 1,503
Testing effectiveness (Phase 2)Looking for participantsNCT05726292
What this trial is testing

Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Chicago 90
Testing effectiveness (Phase 2)Looking for participantsNCT06402357
What this trial is testing

High Intensity Focused Ultrasound in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Florida 25
Not applicableUnknownNCT04239599
What this trial is testing

Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 178
Not applicableActive Not RecruitingNCT02296229
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage III Prostate Cancer
Jonsson Comprehensive Cancer Center 220
Testing effectiveness (Phase 2)WithdrawnNCT04569461
What this trial is testing

Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)

Who this might be right for
Prostate Cancer
Duke University
Testing effectiveness (Phase 2)WithdrawnNCT06218667
What this trial is testing

Copanlisib in Combination with Degarelix in People with Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00193271
What this trial is testing

Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
SCRI Development Innovations, LLC 30
Testing effectiveness (Phase 2)WithdrawnNCT04020094
What this trial is testing

Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
University of Utah
Not applicableEnded earlyNCT05826470
What this trial is testing

Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

Who this might be right for
Prostate CancerLow-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen
Genesis Research LLC 4
Testing effectiveness (Phase 2)Ended earlyNCT00577356
What this trial is testing

Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Benaroya Research Institute 6
Testing effectiveness (Phase 2)Ended earlyNCT01695473
What this trial is testing

Neoadjuvant BKM120 in High-risk Prostate Cancer

Who this might be right for
High Risk Prostate Cancer
Won Kim 11
Next Page